New scoring system could rate robot thyroid surgeons
NCT ID NCT06730321
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to create and test a scoring system called RTAS to evaluate how well surgeons perform robotic thyroidectomy, a surgery to remove all or part of the thyroid gland. Researchers will observe 200 participants with thyroid cancer or benign nodules who are having this surgery. The goal is to develop a tool that can help train surgeons and improve surgical quality.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a reliable way to measure and improve surgeon performance in robotic thyroidectomy, potentially leading to better patient outcomes and standardized training.
- What could go wrong
- This is an observational study focused on developing an assessment tool, not testing a treatment. The scoring system may not fully capture surgical quality or improve actual patient results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2024
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients were well informed about the robotic thyroidectomy and were aware of the potential benefits and risks. Patients underwent robotic thyroidectomy during the study period. Patient consented for us to use perioperative data.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm * Clinical diagnosis of benign thyroid nodules with a maximum diameter not exceeding 6 cm * Participants with high cosmetic expectations * Participants underwent robotic thyroidectomy without open conversion Exclusion Criteria: * Participants with history of neck surgery or radiation * Participants with vocal fold fixation by preoperative fibrolaryngoscope * Participants with preoperative examination suggestive of distant invasion * Participants with fusion or fixed of lymph nodes in the neck
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign thyroid nodule are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Shanghai Sixth People's Hospital
RECRUITINGShanghai, 200233, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light-Based probe aims to spot thyroid cancer faster
- Pregnancy hormone hCG may hold clues to bone and gland health
- Mapping how thyroid tumors spread and what surgery leaves behind
- Antibody-Drug conjugate targets TROP-2 in Hard-to-Treat thyroid cancers
- Can a video keep thyroid cancer patients on track after surgery?
- Can doctors safely watch small thyroid cancers instead of removing them?